Navamedic ASA: Annual Report 2023
Oslo, 30 April 30 2024 - Navamedic ASA has today published its Annual Report for 2023 approved by the Board of Directors. Find enclosed the report in PDF as well as an ESEF file version. The report is also made available at the company's website at https://navamedic.com/investors/annual-reports/
For further information, please contact:
Kathrine Gamborg Andreassen, CEO, Navamedic Mobile: +47 951 78 680 E-mail: [email protected]
Lars Hjarrand, CFO, Navamedic Mobile: +47917 62 842 E-mail: [email protected]
About Navamedic
Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in the UK and Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (ticker: NAVA). For more information, please visit www.navamedic.com.
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.
